EMJ Podcast: COVID-19’s Impact on Atopic Dermatitis - European Medical Journal

EMJ Podcast: COVID-19’s Impact on Atopic Dermatitis

Bonus Episode | 15 FEBRUARY 2021

COVID-19’s Impact on Atopic Dermatitis

This episode, sponsored by an educational grant from Sanofi Genzyme and Regeneron, is the first of a five-part series exploring dermatology and the subject of atopic dermatitis (AD). Hear from Dr Miriam Wittmann, Associate Professor, Inflammatory Skin Diseases, The University of Leeds, who focuses on the COVID-19 pandemic and its impact on AD research.

Spotify | AppleDownload MP3 (mp3, 25:27 mins)

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given